The first signs of beta-cell autoimmunity appear in infancy in genetically susceptible children from the general population: the Finnish Type 1 Diabetes Prediction and Prevention Study.

Little is known about the timing of the etiological events and the preclinical process of type 1 diabetes during the first years of life in the general population. In this population-based prospective birth cohort study, the appearance of diabetes-associated autoantibodies as a sign of beta-cell autoimmunity and the development of type 1 diabetes were monitored from birth. Of 25,983 newborn infants, 2,448 genetically susceptible children were monitored for islet cell antibodies (ICA) at 3- to 6-month intervals. If an infant seroconverted to ICA positivity, all his/her samples were also analyzed for insulin autoantibodies (IAA), antibodies to the 65-kDa isoform of glutamic acid decarboxylase, and antibodies to the protein tyrosine phosphatase-related IA-2 molecule. Fifteen children of those who carried the high-risk genotype (2.7%) and 23 of those who carried the moderate-risk genotype (1.2%; P = 0.019) tested positive for ICA at least once. Among those who showed positivity for at least 2 antibodies during the observation period (25 of 38), IAA appeared as the first or among the first antibodies in 22 children (88%) and emerged earlier than the other antibodies (P < 0.019 or less). The first autoantibodies appeared in the majority of the children in the fall and winter (30 of 38 vs. 8 of 38 in the spring and summer, P < 0.001). These observations suggest that young children in the general population with a strong human-leukocyte-antigen-DQ-defined genetic risk of type 1 diabetes show signs of beta-cell autoimmunity proportionally more often than those with a moderate genetic risk. IAA emerge as the first detectable antibody more commonly than any other antibody specificity, implying that insulin may be the primary antigen in most cases of human type 1 diabetes associated with the DR4-DQB1*0302 haplotype. The seasonal variation in the emergence of the first signs of beta-cell autoimmunity suggests that infectious agents may play a role in the induction of such autoimmunity.

[1]  P. Bingley,et al.  Combined use of autoantibodies (IA-2 autoantibody, GAD autoantibody, insulin autoantibody, cytoplasmic islet cell antibodies) in type 1 diabetes: Combinatorial Islet Autoantibody Workshop. , 1998, Diabetes.

[2]  J. Ilonen,et al.  A comparison of childhood and adult type I diabetes mellitus. , 1989, The New England journal of medicine.

[3]  P. Bingley,et al.  A novel micro-assay for insulin autoantibodies. , 1997, Journal of autoimmunity.

[4]  J. Ilonen,et al.  Disease-Associated Antibodies in Offspring of Mothers with IDDM , 1996, Diabetes.

[5]  E. Bonifacio,et al.  IA-2 antibodies – a sensitive marker of IDDM with clinical onset in childhood and adolescence , 1998, Diabetologia.

[6]  J A Swets,et al.  Measuring the accuracy of diagnostic systems. , 1988, Science.

[7]  M. Knip,et al.  Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes. A population-based study. The Childhood Diabetes in Finland Study Group. , 1998, The Journal of clinical investigation.

[8]  Graham-Stewart Cw.  TERMINATION OF PREGNANCY ON PSYCHIATRIC GROUNDS. , 1964 .

[9]  A. Hämäläinen,et al.  Feasibility of genetic and immunological prediction of Type I diabetes in a population-based birth cohort , 2001, Diabetologia.

[10]  J. Ilonen,et al.  Disease‐associated autoantibodies and HLA‐DQB1 genotypes in children with newly diagnosed insulin‐dependent diabetes mellitus (IDDM) , 1999, Clinical and experimental immunology.

[11]  A. Ziegler,et al.  Perinatal Autoimmunity in Offspring of Diabetic Parents: The German Multicenter BABY-DIAB Study: Detection of Humoral Immune Responses to Islet Antigens in Early Childhood , 1996, Diabetes.

[12]  E. Bonifacio,et al.  Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. , 1999, Diabetes.

[13]  M. Rewers,et al.  Transient antiislet autoantibodies: infrequent occurrence and lack of association with "genetic" risk factors. , 2000, The Journal of clinical endocrinology and metabolism.

[14]  D. Doniach,et al.  Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. , 1974, Lancet.

[15]  M. Rewers,et al.  Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. Ilonen,et al.  HLA-DQB1-defined genetic susceptibility, beta cell autoimmunity, and metabolic characteristics in familial and nonfamilial insulin-dependent diabetes mellitus. Childhood Diabetes in Finland (DiMe) Study Group. , 1996, The Journal of clinical investigation.

[17]  J. Ilonen,et al.  Rapid HLA-DQB1 Genotyping for Four Alleles in the Assessment of Risk for IDDM in the Finnish Population , 1996, Diabetes Care.

[18]  M. Knip,et al.  Disease-associated autoimmunity and prevention of insulin-dependent diabetes mellitus. , 1997, Annals of medicine.

[19]  M. Knip,et al.  A Prospective Study of the Role of Coxsackie B and Other Enterovirus Infections in the Pathogenesis of IDDM , 1995, Diabetes.

[20]  G. Eisenbarth.  Mouse or Man: Is GAD the cause of type I diabetes? , 1994, Diabetes Care.

[21]  J. Tuomilehto,et al.  Record-high incidence of Type I (insulin-dependent) diabetes mellitus in Finnish children , 1999, Diabetologia.

[22]  J. Ilonen,et al.  Short-term exclusive breastfeeding predisposes young children with increased genetic risk of Type I diabetes to progressive beta-cell autoimmunity , 2001, Diabetologia.

[23]  J. Ilonen,et al.  Relation Between Insulin Antibody and Complement-Fixing Islet Cell Antibody at Clinical Diagnosis of IDDM , 1986, Diabetes.

[24]  J. Ilonen,et al.  Islet cell antibody seroconversion in children is temporally associated with enterovirus infections. Childhood Diabetes in Finland (DiMe) Study Group. , 1997, The Journal of infectious diseases.

[25]  M. Eberhardt,et al.  Correlates of Insulin Antibodies in Newly Diagnosed Children with Insulin-dependent Diabetes Before Insulin Therapy , 1985, Diabetes.

[26]  J. Ilonen,et al.  Autoantibodies associated with Type I diabetes mellitus persist after diagnosis in children , 1998, Diabetologia.

[27]  P. Bingley,et al.  Combined Analysis of Autoantibodies Improves Prediction of IDDM in Islet Cell Antibody-Positive Relatives , 1994, Diabetes.

[28]  A. Hämäläinen,et al.  Cow's milk formula feeding induces primary immunization to insulin in infants at genetic risk for type 1 diabetes. , 1999, Diabetes.

[29]  J. Ilonen,et al.  Triple-label hybridization assay for type-1 diabetes-related HLA alleles. , 1995, BioTechniques.

[30]  D. Wegmann,et al.  Epitope specificity, cytokine production profile and diabetogenic activity of insulin‐specific T cell clones isolated from NOD mice , 1995, European journal of immunology.

[31]  P. Björntorp,et al.  Seasonal influence on insulin secretion in man. , 1971, Clinical science.

[32]  J. Ilonen,et al.  Costs of predicting IDDM , 1998, Diabetologia.

[33]  H. Chase,et al.  Altered immune response to insulin in newly diagnosed compared to insulin-treated diabetic patients and healthy control subjects , 1997, Diabetologia.

[34]  S. Garg,et al.  Genetic determination of islet cell autoimmunity in monozygotic twin, dizygotic twin, and non-twin siblings of patients with type 1 diabetes: prospective twin study , 1999, BMJ.

[35]  E. Gale,et al.  Rising Incidence of IDDM in Europe , 1989, Diabetes Care.